{"id":"W4409349036","doi":"10.1016/j.jhep.2025.03.033","title":"Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC","year":2025,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"AstraZeneca; AstraZeneca United States","keywords":"Durvalumab; Tremelimumab; Medicine; Oncology; Internal medicine; Cancer; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004169543,0.0002582747,0.0009717877,0.000655741,0.0002737963,0.001115761,0.00049295,0.0003196004,0.001104064],"category_scores_gemma":[0.003877032,0.0002219683,0.0008823036,0.001435203,0.0001831008,0.0003992224,0.000572786,0.0006101685,0.0002784002],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008572498,"about_ca_system_score_gemma":0.0009934807,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008310185,"about_ca_topic_score_gemma":0.01030032,"domain_scores_codex":[0.9986683,0.0006054291,0.0001237661,0.0001317538,0.0003591422,0.0001115307],"domain_scores_gemma":[0.9958489,0.00100942,0.00123717,0.0005441831,0.0008250295,0.0005352435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06926899,0.0005709355,0.7672063,0.001761447,0.01011911,0.000474943,0.001015247,0.002355931,0.002556093,0.0004187831,0.01648957,0.1277626],"study_design_scores_gemma":[0.002418709,0.001652994,0.9773574,0.0001486542,0.003860947,0.0003137742,0.0001128181,0.0003934335,0.000513679,0.0001073784,0.01308524,0.00003491048],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9448506,0.01618067,0.000926674,0.0008782203,0.0001446416,0.0003447295,0.03134518,0.00006196693,0.00526728],"genre_scores_gemma":[0.9663116,0.002851844,0.000765087,0.0005421686,0.0001942661,0.0003206079,0.02807364,0.00002003723,0.0009206913],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008310185,"threshold_uncertainty_score":0.02205092,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0176986433370237,"score_gpt":0.3006867565239298,"score_spread":0.2829881131869061,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}